Hologic gains FDA approval for newly-acquired genotype assay; St. Jude Medical deals with multiple downgrades;

 @FierceMedDev: Michael Mahoney, Boston Scientific's new CEO, inherits a giant in transition on day one. More | Follow @FierceMedDev

 @MarkHFierce: Advanced Cell Diagnostics pulled in $12 million in new Series B financing. More | Follow @MarkHFierce

 @DamianFierce: It's campaign season, and medical device companies are donating big. Find out how and to whom in our report. More | Follow @DamianFierce

> Hologic's ($HOLX) Gen-Probe division got FDA approval for its Aptima HPV genotype assay, using RNA markers to detect the virus. News

> With 510(k) clearance in hand, Teleflex ($TFX) is launching the Arrow FlexBlock, a continuous nerve peripheral nerve block catheter. More

> Adding to its list of woes this year, St. Jude Medical ($STJ) has been hit with 5 back-to-back downgrades from equity analysts. Story

> Danaher Corporation ($DHR) has completed its $338 million acquisition of diagnostics company Iris International. Item (reg. req.)

> Italian medical device maker the Sorin Group said earthquakes slashed profits nearly 100% during its third quarter. Story

> NeuroMetrix sealed a distribution deal with OneSource Medical Group for its Sensus pain management device. Item

> Ireland's HiberGene Diagnostics has named Tony Hill it new CEO. Hill was previously a vice president at OraSure Technologies. Article

Biotech News

 @FierceBiotech: Trending on FierceBiotech.com : The 2012 Biotech Graveyard. Special Report | Follow @FierceBiotech

 @JohnCFierce: Medivir would like everyone to know that JNJ's hep C drug came from them. Alios outlicensed Vertex drug, but they've always been low profile. | Follow @JohnCFierce

 @RyanMFierce: Sanofi deal bolsters Medidata in record quarter for revenue, boosts number of cloud customers in pharma. More | Follow @RyanMFierce

> Hurricane Sandy flooding wipes out years of drug research at NYU lab. Story

> Vertex partners with J&J, GlaxoSmithKline on new hep C combos. News

> FDA spurns new low-sodium drug from Cornerstone. Article

Pharma News

@FiercePharma: Spectrum rejigs sales ops after Allos buyout, to tout its 3-drug stable. Prep for new ones, too. More | Follow @FiercePharma

> Pfizer discloses $491M charge for Rapamune marketing settlement. Article

> Switzerland, Canada clear Novartis flu vaccines after tests. News

Vaccines News

 @AlisonBFierce: In search of a lasting flu vaccine: Researchers work to find decades of protection with one shot. More | Follow @AlisonBFierce

> Health officials clash over whether to scrap malaria program. Item

> Mumps vaccine succumbs to face-to-face contact. Story

> U.K.'s HPA lands $6.4M for anthrax vaccine research. Article

> Study: Flu vaccine protects against heart attacks. More

Pharma Manufacturing News

> Lonza whacking 500 jobs, 400 at Swiss API plant. Story

> Compounder recall may make drug shortages more severe. News

> Novartis adding $500M biologics plant in Singapore. Report

> Boston-area pharma plant goes up for auction to pay debts. More